Assessment of serum levels of ischemia modified albumin and interleukin-17 in children with atopic dermatitis

Shaimaa Ismail Omar,Nagat sobhy Mohamed,Nermeen Eldabah,Eman Abdalhakim
DOI: https://doi.org/10.1007/s00403-024-03366-6
2024-09-29
Archives of Dermatological Research
Abstract:Atopic dermatitis (AD) is the most prevalent chronic inflammatory skin disease in childhood. Interleukin 17 (IL17) is one of the pro-inflammatory cytokines that has an important role in the pathogenesis of many skin diseases including AD. Ischemia modified albumin (IMA) is an indicator of oxidative stress, inflammation and ischemia. The aim of the study was to assess the IL-17 and IMA serum levels in the children patients with AD in comparison to a control group. Additionally, the study seeks to examine the correlation between these biomarkers and their association with disease severity, disease stages, and other clinical characteristics.
dermatology
What problem does this paper attempt to address?